IsoStent, Inc.

START-UP interviews four of the most productive medical device inventors and company creators in the industry, and they’re all members of the Fischell family. By Mary Stuart Robert Fischell and his th

Cordis built up a $500 million stent business and then watched virtually all of it slip away. Now, it's back with a host of new products and its sites set on being number one again. by David Cassak Wh

Novoste is out to show that the changing device world still has room, in the right market, for a small single-product company to succeed against larger competitors. by Stephen Levin For someone who ot

by Wendy Diller In the year and a half since Johnson & Johnson received FDA approval for the first coronary stent for prevention of restenosis following balloon angioplasty, the market for the devi